Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
61 studies found for:    ctDNA | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Circulating Tumour DNA (ctDNA) Rectal Cancer and the Relationship to Extramural Venous Invasion
Conditions: Cancer;   Rectal Cancer
Interventions: Other: Blood sample (mrEMVI positive patient);   Other: Blood sample (mrEMVI negative patient)
2 Recruiting Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma
Condition: Adenocarcinoma of Lung (Disorder)
Intervention: Genetic: Sequencing of ctDNA in plasma
3 Recruiting Use of ctDNA for Monitoring of Stage III Colorectal Cancer
Condition: Stage III Colorectal Cancer
Intervention:
4 Recruiting ctDNA in Patients With Thyroid Nodules
Conditions: Thyroid Cancer;   Thyroid Nodules;   Thyroid Adenoma;   Thyroiditis
Intervention:
5 Recruiting Clinical Application of CTDNA in Operable Breast Cancer Patients
Condition: Breast Cancer
Interventions: Procedure: Neoadjuvant chemotherapy before surgery;   Procedure: Surgery followed by adjuvant chemotherapy
6 Not yet recruiting ctDNA for Prediction of Relapse in Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Other: ctDNA test
7 Not yet recruiting The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer
Condition: Neoplasms, Gastrointestinal
Intervention:
8 Recruiting Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention:
9 Not yet recruiting Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer
Conditions: Rectal Cancer, Adenocarcinoma;   Neoadjuvant Chemoradiation
Interventions: Drug: Capecitabine +/- Oxaliplatin;   Procedure: local resection;   Procedure: radical resection;   Other: No adjuvant chemotherapy
10 Not yet recruiting ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC
Conditions: Non-small Cell Lung Cancer Stage III;   Non-Small-Cell Lung Cancer Metastatic;   Adenocarcinoma of Lung;   EGFR Wildtype
Intervention: Genetic: ctDNA analysis
11 Recruiting Concordance Between ctDNA Assay and FoundationOne
Conditions: Circulating Tumor DNA;   Cancer;   Neoplasms;   Genomic Testing;   Genomic Alterations
Intervention:
12 Recruiting Circulating Tumor DNA in Patients at High Risk for Lung Cancer
Conditions: Cancer of the Lung;   Lung Cancer;   Lung Neoplasms;   Adenocarcinoma of the Lung;   Non Small Cell Carcinoma of the Lung;   Small Cell Carcinoma of the Lung
Intervention:
13 Recruiting The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer
Condition: Biliary Tract Neoplasms
Intervention: Procedure: surgery or biopsy
14 Recruiting EGFR Mutations on ctDNA in Patients With Advanced NSCLC
Conditions: Non-small Cell Lung Cancer Stage III;   Non-Small-Cell Lung Cancer Metastatic
Interventions: Other: mutation detection;   Other: ARMS;   Genetic: ctDNA analysis
15 Recruiting Cambridge Liquid Biopsy and Tumour Profiling Study for Patients on Experimental Therapeutics Trials
Condition: Cancer
Intervention:
16 Recruiting Detection of Heterogeneity in Central Lung Cancer - EBUS-TBNA and ctDNA Analysis vs. Endobronchial Forceps Biopsy
Condition: Lung Neoplasms
Interventions: Procedure: EBUS-TBNA;   Procedure: Endobronchial forceps biopsy
17 Recruiting A Prospective, Observational Trial on the Diagnostic and Prognostic of LM
Conditions: Lung Neoplasms;   Meningeal Carcinomatosis
Intervention:
18 Recruiting Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies
Conditions: Head and Neck Cancer;   Melanoma
Intervention:
19 Recruiting PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection
Condition: Metastatic Breast Cancer
Interventions: Drug: Palbociclib 125mg;   Drug: Aromatase Inhibitors;   Drug: Fulvestrant Injectable Product
20 Not yet recruiting Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study
Conditions: Carcinoma;   Non-small-cell Lung Cancer;   Lung Neoplasms
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.